Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.19USD
13 Dec 2017
Change (% chg)

$0.19 (+6.33%)
Prev Close
$3.00
Open
$2.98
Day's High
$3.25
Day's Low
$2.98
Volume
7,999
Avg. Vol
9,179
52-wk High
$5.55
52-wk Low
$1.22

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.35
Market Cap(Mil.): $36.10
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

BRIEF-Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11

* Cleveland BioLabs reports third quarter 2017 financial results and development progress

Nov 14 2017

BRIEF-Cleveland BioLabs Q2 loss per share $0.50‍​

* Cleveland BioLabs reports second quarter 2017 financial results and development progress

Aug 14 2017

Earnings vs. Estimates